PTU - Polskie Towarzystwo Urologiczne
home page
current numbers
archival numbers
list of articles:
list przewodni/covering letter
editor
Scientific Committee
publisher
subscription
advertising
important links

Comparison of the effectiveness of sy stemic treatment with cyclophosphamide and BCG sec Berna administe red intravesically for prevention of recurrences of primary superficial bladder tumours
Article published in Urologia Polska 1991/44/2.

authors

Andrzej Stokłosa, Jan Antczak, Andrzej W. Malewski, Jacek Rykowski, Ewa KoĽmińska, Jan Szymanowski
Z Oddziału Urologii Szpitala Bielańskiego w Warszawie Ordynator Oddziału: dr n. med. J. Szymanowski

summary

Thirty-eight patients with superficial bladder cancer (Ta, Tl, Tis) after transurethral electroresection of the tumour were divided at random into two groups. Group 1 (21 patients) received three times at 4-week intervals intravenously cyclophosphamide 1.5 g/m2. Group 2 (17 patients) received one ampoule of BCG vaccine, Berna strain, intravesically in 50 ml of normal saline obce weekly for six weeks.
A Comparison of the therapeutic results demonstrated a high effectiveness of BCG — 58.3% of the patients without recurrence, as compared with a less evident usefulness of cyclophospmaide — 35.0°/o without recurrence.

references

  1. 1. Boyd P. J. R., Burnand K. C: Site bladder tumor recurrences. Lancet, 1974, 1, 1290, —
  2. 2. Brenner D. W., Schellchammer P. F.:Upper tract urothelial malignancy after cyclophosphamide therapy: a case report and literature review. J. Urol., 1987, 137, 1226. —
  3. 3. Cooper P. H., Waisman J., Johnston W. H., Skinner D.G.:Severe atypia of transitional epithelium and carcinoma of the urinary bladder. Cancer, 1973, 31, 1055. —
  4. 4. Green D. F., Robinson M. R. C, Glashan R.,Newling D., Dalesio O., Smith P. H.: Does intravesical chemotherapy provent invas.ive bladder cancer? J. Urol., 1984. 131, 33. —
  5. 5. Hudson A. AT., Ratliff T. L., Gillen D. P., Haaff E. O., Dresner S. M., Catalona W. J.: Single course versus maintenance bacillus Calmette-Guerin therapy for superficial bladder tumors: a prospective, randomized trial. J. Urol., 1987, 138, 295. —
  6. 6. Heney N. M., Daly J., Prout G, R., Nieh P. T., Hearney J . A., Trebeck N. E.: Biopsy of apparently normal urothelium dn patients with bladder carcinoma. J. Urol., 1978,120, 550. —
  7. 7. Kavousi L. R., Torrence R. J., Gillen D. P., Hudson A. M.,Haaff E.O., Dresner S. M., Ratliff T. L., Catalona W. J.: Results of 6 weekly intravesical Bacillus Calmette-Guerin instillations on the treatment of superficial Nr 2 A. Stokłosa i inni 93 bladder tumors. J. Urol., 1988, 139,935.
  8. 8. Levine L. A., Richie J. P.:Urological complications of cyclophosphamide. J. Urol., 1989, 141, 1063. —
  9. 9. Logothesis C. J., Johnson D. E., Chang C, Dexeus F. H., Ogden S., Eschenbach A., Ayala A.: Adjuvant chemotherapy of bladder cancer: a preliminary report. J. Urol., 1988, 139, 1207. —
  10. 10. Lermn R. J., Hutter R. V. P., Whitmore W. F.: Papilloma of the urinary bladder. Cancer, 1979, 333.
  11. 11. Morales A., Eidinger D., Bruce A.: Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder cancer. J. Urol., 1976, 116, 180. —
  12. 12. Morales A.: .Long-term results and complications of intracavitary bacillus Calmette-Guerin therapy for bladder cancer. J. Urol., 1984, 132, 457. —
  13. 13. Pearson R. M., Soloway M. S.: Does cyclophosphamide induce bladder cancer? Urology 1978, 11, 437. —
  14. 14. Pyrah L. N., Raper F. P.: Report of a follow-up of papilla-ry tumours of the bladder. Brit. J. Urol., 1964, 36, 4. — 15, Shade R. O. K., Swinney J.: The association of urothelial atypism with neoplasia: Its importance in treatment and prognosis. J. Urol., 1973, 109, 619.
  15. 16. Soloway M. S., Murphy W. M., Rao M. K., Cox C. E.: Serial multiple-site biopsies in patients with bladder cancer. J. Urol., 1978, 120, 56. —
  16. 17. Soloway M.: Rationale for intensive intravesical chemotherapy for superficial bladder cancer. J. Urol. 1930, 123, 461. —
  17. 18. Torrence R. J., Kavoussi L. R., Catalona W. J., Ratliff T. L.: Prognostic factors in patients treated with intravesical bacillus Calmette-Guerin for superficial bladder cancer. J. Urol., 1988, 139, 941. —
  18. 19. Weldon T. E., Soloway M. S.:Susceptibility of urothelium to neoplastic cellular implantation. Urology, 1975, 5, 824.

correspondence

lek. med. Andrzej Stokłosa, 01-391 Warszawa, ul. Anieli Krzywoń 4 m. 13